In a significant development within the sports technology and women's health sector, the AI bio-analytics platform Orreco has completed the acquisition of Jennis, a pioneering women's hormone health and performance platform established by Olympic gold medallist Dame Jessica Ennis-Hill. This strategic move follows a substantial $4 million Series A funding round for Orreco, which was led by the prominent billionaire tech investor and Dallas Mavericks minority owner, Mark Cuban.
Building a comprehensive women's performance ecosystem
Orreco, known for its advanced artificial intelligence analytics, is integrating Jennis into its growing portfolio of subsidiaries. This includes FitrWoman, a platform utilised by elite teams such as England's Lionesses football squad, and DDSA Computer Vision, a firm specialising in biomechanical insights used by tennis champion Aryna Sabalenka. The acquisition is designed to create what Orreco describes as "the most advanced women's performance ecosystem in the world."
A unified intelligence platform
Dr Brian Moore, co-founder of Orreco, emphasised that this is not merely a collection of separate tools but a cohesive, single intelligence platform. He stated, "By uniting Orreco AI with FitrWoman, Jennis IP, and DDSA computer vision, we are redefining how women's performance is measured, understood, and optimised." The company aims to set a new global benchmark by combining hormonal health intellectual property from Jennis, menstrual-cycle intelligence from FitrWoman, biomechanics from DDSA, and Orreco's proprietary AI analytics.
Enthusiasm from an Olympic champion
Dame Jessica Ennis-Hill, who founded Jennis and won heptathlon gold at the London 2012 Olympics, expressed her excitement about joining the Orreco team. She highlighted Orreco's vision and success in the elite women's sports space, noting, "I am delighted to join their team at this very exciting time to help open more conversations with sportswomen and teams." Ennis-Hill further remarked on the potential of Orreco's @thlete platform, stating that its application to elite sportswomen and teams represents a "game changer" for achieving marginal gains in performance.
Strategic implications and future prospects
The acquisition underscores a growing trend towards leveraging technology and data analytics to enhance athletic performance and wellbeing, particularly in women's sports. Jennis will contribute its specialist training programmes and wellness guidance to Orreco's ecosystem, which employs AI to integrate biological data across platforms. This development is poised to impact not only elite sport but also broader healthcare and consumer wellbeing sectors, offering tailored insights and support for women at all levels of physical activity.
